Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by flycrazyon Feb 21, 2019 1:54am

396 Views

Post# 29392087

RE:OUCH! Aphria will be on your heels.

Vinny57 wrote:

SMITHS FALLS, ON, Feb. 20, 2019 /CNW/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or "the Company") filed its Amended and Restated Management Discussion and Analysis for the three and nine months ended December 31, 2018 ("Amended MD&A") to correct the Adjusted EBITDA¹ in the original MD&A for the nine months ended December 31, 2018 filed on February 14, 2019 (the "Original MD&A"), as follows.

The correction of the Adjusted EBITDA loss for the nine months ended December 31, 2018 from $69,006,000 to $155,154,000. The correction was made due to a formula error in the spreadsheet supporting the year to date Adjusted EBITDA loss calculation. The Adjusted EBITDA loss for the three months ended as December 31, 2018 was correct as reported, as were all prior quarters as released.